Identification and Impact of Aggregation‐Prone Regions in Proteins and Therapeutic Monoclonal Antibodies

[1]  Francesc X. Avilés,et al.  AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides , 2007, BMC Bioinform..

[2]  R. Nussinov,et al.  Folding and binding cascades: Dynamic landscapes and population shifts , 2008, Protein science : a publication of the Protein Society.

[3]  K. Dill,et al.  From Levinthal to pathways to funnels , 1997, Nature Structural Biology.

[4]  L. Tjernberg,et al.  Charge Attraction and β Propensity Are Necessary for Amyloid Fibril Formation from Tetrapeptides* , 2002, The Journal of Biological Chemistry.

[5]  A Caflisch,et al.  A molecular dynamics approach to the structural characterization of amyloid aggregation. , 2006, Journal of molecular biology.

[6]  Amedeo Caflisch,et al.  Prediction of aggregation rate and aggregation‐prone segments in polypeptide sequences , 2005, Protein science : a publication of the Protein Society.

[7]  Michele Vendruscolo,et al.  Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. , 2005, Journal of molecular biology.

[8]  P. Carter.  Potent antibody therapeutics by design , 2006, Nature Reviews Immunology.

[9]  David Eisenberg,et al.  Recent atomic models of amyloid fibril structure. , 2006, Current opinion in structural biology.

[10]  S. A. Marshall,et al.  Rational design and engineering of therapeutic proteins. , 2003, Drug discovery today.

[11]  D. Baker,et al.  The 3D profile method for identifying fibril-forming segments of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Michael G B Drew,et al.  Water-soluble tripeptide Abeta (9-11) forms amyloid-like fibrils and exhibits neurotoxicity. , 2008, Organic letters.

[13]  Robert A. Grothe,et al.  Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.

[14]  Michail Yu. Lobanov,et al.  Prediction of Amyloidogenic and Disordered Regions in Protein Chains , 2006, PLoS Comput. Biol..

[15]  J. Richardson,et al.  Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Michele Vendruscolo,et al.  Physicochemical principles that regulate the competition between functional and dysfunctional association of proteins , 2009, Proceedings of the National Academy of Sciences.

[17]  Michele Vendruscolo,et al.  The distribution of residues in a polypeptide sequence is a determinant of aggregation optimized by evolution. , 2007, Biophysical journal.

[18]  Louise C. Serpell,et al.  A simple algorithm locates β‐strands in the amyloid fibril core of α‐synuclein, Aβ, and tau using the amino acid sequence alone , 2007 .

[19]  Dusan Bratko,et al.  Molecular simulation of protein aggregation , 2007, Biotechnology and bioengineering.

[20]  Flavio Seno,et al.  Insight into the Structure of Amyloid Fibrils from the Analysis of Globular Proteins , 2006, PLoS Comput. Biol..

[21]  Bernhardt L. Trout,et al.  Design of therapeutic proteins with enhanced stability , 2009, Proceedings of the National Academy of Sciences.

[22]  Regina M Murphy,et al.  Peptide aggregation in neurodegenerative disease. , 2002, Annual review of biomedical engineering.

[23]  Dusan Bratko,et al.  Protein aggregation in silico. , 2007, Trends in biotechnology.

[24]  Silvio C. E. Tosatto,et al.  The PASTA server for protein aggregation prediction. , 2007, Protein engineering, design & selection : PEDS.

[25]  Michele Vendruscolo,et al.  Prediction of aggregation-prone regions in structured proteins. , 2008, Journal of molecular biology.

[26]  D. Eisenberg,et al.  Bacterial Inclusion Bodies Contain Amyloid-Like Structure , 2008, PLoS biology.

[27]  Wim Jiskoot,et al.  A Role for Protein Misfolding in Immunogenicity of Biopharmaceuticals* , 2007, Journal of Biological Chemistry.

[28]  Andreas Vitalis,et al.  Atomistic simulations of the effects of polyglutamine chain length and solvent quality on conformational equilibria and spontaneous homodimerization. , 2008, Journal of molecular biology.

[29]  Michele Vendruscolo,et al.  Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. , 2004, Journal of molecular biology.

[30]  Hao Chen,et al.  Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential , 2007, Bioinform..

[31]  R. Nussinov,et al.  Folding funnels, binding funnels, and protein function , 1999, Protein science : a publication of the Protein Society.

[32]  C. Pace,et al.  Amino acid contribution to protein solubility: Asp, Glu, and Ser contribute more favorably than the other hydrophilic amino acids in RNase Sa. , 2007, Journal of molecular biology.

[33]  D. Otzen,et al.  Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Bernhardt L Trout,et al.  Aggregation-prone motifs in human immunoglobulin G. , 2009, Journal of molecular biology.

[35]  A. Rosenberg,et al.  Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.

[36]  Joost Schymkowitz,et al.  Protein sequences encode safeguards against aggregation , 2009, Human mutation.

[37]  Fred Jacobson,et al.  Protein aggregation and bioprocessing , 2006, The AAPS Journal.

[38]  L. Serrano,et al.  Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.

[39]  Salvador Ventura,et al.  Prediction of "hot spots" of aggregation in disease-linked polypeptides , 2005, BMC Structural Biology.

[40]  Sheldon Park,et al.  Computational design of protein therapeutics. , 2008, Drug discovery today. Technologies.

[41]  C. Dobson,et al.  Competition between folding, native-state dimerisation and amyloid aggregation in beta-lactoglobulin. , 2009, Journal of molecular biology.

[42]  Sandeep Kumar,et al.  Potential aggregation prone regions in biotherapeutics , 2009, mAbs.

[43]  R. Borchardt,et al.  Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.